Best Treatment Option for Patients With Refractory Aggressive B-Cell Lymphoma in the CAR-T Cell Era: Real-World Evidence From GELTAMO/GETH Spanish Groups
- Bastos-Oreiro, M.
- Gutierrez, A.
- Reguera, J.L.
- Iacoboni, G.
- López-Corral, L.
- Terol, M.J.
- Ortíz-Maldonado, V.
- Sanz, J.
- Guerra-Dominguez, L.
- Bailen, R.
- Mussetti, A.
- Abrisqueta, P.
- Hernani, R.
- Luzardo, H.
- Sancho, J.-M.
- Delgado-Serrano, J.
- Salar, A.
- Grande, C.
- Bento, L.
- González de Villambrosía, S.
- García-Belmonte, D.
- Sureda, A.
- Pérez-Martínez, A.
- Barba, P.
- Kwon, M.
- Martín García-Sancho, A.
- Montrer des auteurs +
Revue:
Frontiers in Immunology
ISSN: 1664-3224
Année de publication: 2022
Volumen: 13
Type: Article
